Cryo-Cell International Inc
AMEX:CCEL
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.19
9.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CCEL stock under the Base Case scenario is 6.22 USD. Compared to the current market price of 7.34 USD, Cryo-Cell International Inc is Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cryo-Cell International Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CCEL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cryo-Cell International Inc
Balance Sheet Decomposition
Cryo-Cell International Inc
Current Assets | 10.2m |
Cash & Short-Term Investments | 1.5m |
Receivables | 6.8m |
Other Current Assets | 1.8m |
Non-Current Assets | 52.4m |
PP&E | 23m |
Intangibles | 2.9m |
Other Non-Current Assets | 26.5m |
Current Liabilities | 19.4m |
Accounts Payable | 1.8m |
Accrued Liabilities | 3.5m |
Other Current Liabilities | 14.1m |
Non-Current Liabilities | 53.9m |
Long-Term Debt | 8.4m |
Other Non-Current Liabilities | 45.5m |
Earnings Waterfall
Cryo-Cell International Inc
Revenue
|
31.6m
USD
|
Cost of Revenue
|
-8.4m
USD
|
Gross Profit
|
23.2m
USD
|
Operating Expenses
|
-18.9m
USD
|
Operating Income
|
4.4m
USD
|
Other Expenses
|
-13.6m
USD
|
Net Income
|
-9.3m
USD
|
Free Cash Flow Analysis
Cryo-Cell International Inc
USD | |
Free Cash Flow | USD |
CCEL Profitability Score
Profitability Due Diligence
Cryo-Cell International Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Cryo-Cell International Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
CCEL Solvency Score
Solvency Due Diligence
Cryo-Cell International Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
Cryo-Cell International Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CCEL Price Targets Summary
Cryo-Cell International Inc
According to Wall Street analysts, the average 1-year price target for CCEL is 9.18 USD with a low forecast of 9.09 USD and a high forecast of 9.45 USD.
Dividends
Current shareholder yield for CCEL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CCEL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
Contact
IPO
Employees
Officers
The intrinsic value of one CCEL stock under the Base Case scenario is 6.22 USD.
Compared to the current market price of 7.34 USD, Cryo-Cell International Inc is Overvalued by 15%.